Urine α-fetoprotein and orosomucoid 1 as biomarkers of hepatitis B virus-associated hepatocellular carcinoma

被引:29
|
作者
Zhan, Zhu [1 ,2 ,3 ]
Guan, Yalan [1 ,2 ,3 ]
Mew, Kenley [4 ]
Zeng, Weigiong [1 ,2 ,3 ]
Peng, Mingli [1 ,2 ,3 ]
Hu, Peng [1 ,2 ,3 ]
Yang, Yixuan [1 ,2 ,3 ]
Lu, Yi [1 ,2 ,3 ]
Ren, Hong [1 ,2 ,3 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 2, Dept Infect Dis, Chongqing, Peoples R China
[2] Chongqing Med Univ, Inst Viral Hepatitis, Chongqing, Peoples R China
[3] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Minist Educ, Chongqing, Peoples R China
[4] Chongqing Med Univ, Dept Foreign Language, Chongqing, Peoples R China
关键词
biomarker; hepatocellular carcinoma; proteomic; urine; alpha-fetoprotein; CLINICAL-PRACTICE GUIDELINES; ALPHA-1-ACID GLYCOPROTEIN; PROTEIN; COMBINATION; MANAGEMENT;
D O I
10.1152/ajpgi.00267.2019
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatocellular carcinoma (HCC) is the sixth common malignant tumor worldwide. but current efficient and convenient screening methods remain lacking. This study aimed to discover a diagnostic or a screening biomarker from the urine of hepatitis B virus (HBV)-related HCC patients. We used iTRAQ coupled with mass spectrometry to identify candidate urinary proteins in a discovery cohort (n = 40). The selected proteins were confirmed using ELISA in a validation cohort (n = 140). Diagnostic performance of the selected proteins was assessed using receiver operating characteristic (ROC) and qualitative diagnostic analysis. A total of 96 differentially expressed proteins were identified. Urinary alpha-fetoprotein (u-AFP) and orosomucoid 1 (u-ORM1) were selected as target proteins by bioinformatics analysis and were significantly higher in HCC than in non-HCC patients, as validated by Western blot analysis and ELISA. u-AFP had a strong correlation with serum AFP-L3 (Pearson's r = 0.944, P < 0.0001), indicating that u-AFP may be derived from circulating blood. The area under the curve (AUC) of u-AFP was 0.795 with a sensitivity of 62.5% and a specificity of 95.4%, which showed no significantly difference with scrum AFP (se-AFP). The AUC was 0.864 as u-AFP and u-ORM1 were combined, and they performed much better than u-AFP or u-ORM1 alone. Qualitative diagnostic analysis showed that the positive predictive value of u-AFP was 90.1% and the diagnostic sensitivity of parallel combination of u-AFP and u-ORM1 was 85.1%. Taken together, AFP and ORM1 in the urine may be used as a diagnostic or screening biomarker of HCC, and studies on large samples are needed to validate the result. NEW & NOTEWORTHY This study provides a novel way to find biomarkers of hepatocellular carcinoma (HCC) and a new perspective of alpha-fetoprotein clinical application. The urine reagent strips may be helpful in high epidemic areas of HCC and in low-resource settings.
引用
收藏
页码:G305 / G312
页数:8
相关论文
共 50 条
  • [31] Global Regulation on microRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma
    Liu, Angela M.
    Zhang, Chunsheng
    Burchard, Julja
    Fan, S. T.
    Wong, Kwong-Fai
    Dai, Hongyue
    Poon, Ronnie T.
    Luk, John M.
    OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2011, 15 (03) : 187 - 191
  • [32] Tackling hepatitis B virus-associated hepatocellular carcinoma—the future is now
    Mausumi Bharadwaj
    Gaurav Roy
    Koushik Dutta
    Mohammad Misbah
    Mohammad Husain
    Showket Hussain
    Cancer and Metastasis Reviews, 2013, 32 : 229 - 268
  • [33] High lymphocyte-to-monocyte ratio is associated with low α-fetoprotein expression in patients with hepatitis B virus-associated hepatocellular carcinoma
    Wang, Haixia
    Xiang, Yu
    Li, Xinyu
    Liu, Shuang
    Liu, Linxiu
    MOLECULAR MEDICINE REPORTS, 2020, 22 (04) : 2673 - 2684
  • [34] MicroRNA-122 in patients with hepatitis B and hepatitis B virus-associated hepatocellular carcinoma
    Mahmoudian-Sani, Mohammad Reza
    Asgharzade, Samira
    Alghasi, Arash
    Saeedi-Boroujeni, Ali
    Sadati, Seyed Jafar Adnani
    Moradi, Mohammad Taghi
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 10 (04) : 789 - 796
  • [35] Hypomethylation of the cyclin D1 promoter in hepatitis B virus-associated hepatocellular carcinoma
    Liu, Hui-Hui
    Fang, Yu
    Wang, Jing-Wen
    Yuan, Xiao-Dong
    Fan, Yu-Chen
    Gao, Shuai
    Han, Li-Yan
    Wang, Kai
    MEDICINE, 2020, 99 (20)
  • [36] HLA Zygosity Increases Risk of Hepatitis B Virus-Associated Hepatocellular Carcinoma
    Liu, Zhiwei
    Huang, Chih-Jen
    Huang, Yu-Han
    Pan, Mei-Hung
    Lee, Mei-Hsuan
    Yu, Kelly J.
    Pfeiffer, Ruth M.
    Viard, Mathias
    Yuki, Yuko
    Gao, Xiaojiang
    Carrington, Mary
    Chen, Chien-Jen
    Hildesheim, Allan
    Yang, Hwai-, I
    JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (10): : 1796 - 1805
  • [37] Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV
    Maponga, Tongai Gibson
    Glashoff, Richard H.
    Vermeulen, Hannali
    Robertson, Barbara
    Burmeister, Sean
    Bernon, Marc
    Omoshoro-Jones, Jones
    Ruff, Paul
    Neugut, Alfred, I
    Jacobson, Judith S.
    Preiser, Wolfgang
    Andersson, Monique, I
    BMC GASTROENTEROLOGY, 2020, 20 (01)
  • [38] Silent hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma in Japan.
    Momosaki, S
    Hsia, C
    Nakashima, Y
    Kojiro, M
    Tabor, E
    HEPATOLOGY, 1999, 30 (04) : 637A - 637A
  • [39] HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma
    Momosaki, S
    Nakashima, Y
    Kojiro, M
    Tabor, E
    JOURNAL OF VIRAL HEPATITIS, 2005, 12 (03) : 325 - 329
  • [40] Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV
    Tongai Gibson Maponga
    Richard H. Glashoff
    Hannali Vermeulen
    Barbara Robertson
    Sean Burmeister
    Marc Bernon
    Jones Omoshoro-Jones
    Paul Ruff
    Alfred I. Neugut
    Judith S. Jacobson
    Wolfgang Preiser
    Monique I. Andersson
    BMC Gastroenterology, 20